Invention Grant
- Patent Title: Methods for reducing pulmonary uptake of intravenously injected cells
- Patent Title (中): 降低静脉注射细胞肺吸收的方法
-
Application No.: US13810425Application Date: 2011-07-08
-
Publication No.: US09446066B2Publication Date: 2016-09-20
- Inventor: Olle Korsgren , Bo Nilsson
- Applicant: Olle Korsgren , Bo Nilsson
- Applicant Address: SE Viken
- Assignee: TX MEDIC AB
- Current Assignee: TX MEDIC AB
- Current Assignee Address: SE Viken
- Agency: Porter Wright Morris & Arthur LLP
- International Application: PCT/SE2011/050928 WO 20110708
- International Announcement: WO2012/008908 WO 20120119
- Main IPC: A61K35/26
- IPC: A61K35/26 ; A61K31/737
Abstract:
Dextran sulfate is used in order to reduce pulmonary uptake of intravenously injected Dextran sulfate is capable of reducing the pulmonary uptake of the intravenously injected cells to the levels obtained for intraarterial injection of the cells but without the accompanying risks and side effects of using intraarterial cell injection. The dextran sulfate can therefore be used in a composition together with tumor infiltrating T-lymphocytes to treat metastatic cancer in a subject.
Public/Granted literature
- US20130115200A1 Cell Therapy Public/Granted day:2013-05-09
Information query
IPC分类:
